Gastrointestinal disorders include conditions such as peptic Ulcer, inflammatory bowel diseases IBD (Crohn’s disease & Ulcerative Colitis), irritable bowel syndrome (IBS) & Constipation.


Longer term, market growth exists for IBD and IBS given the continued progression in clinical development of novel drug mechanisms.  These remain as under-diagnosed and underserved conditions that impact very large populations of patients across a wide demographic within developed markets.  


Strong commercial opportunity exist in areas such as Chronic Constipation (CC), Opioid Induced Constipation (OIC), Constipation Predominant Irritable Bowel Syndrome (IBS-C) and diarrhea predominant IBS-D.

Account Login


Once you register for a free online demo

 We would provide a guided tour to help you understand our offerings in detail

 You get a look and feel of our offerings even before you actually pay and subscribe with us

 Post demo once you confirm your interest & make payment ;accordingly, we initiate your annual subscription access

As you are already registered with us we generate your personalized login credentials and share with you

 The personalized login credentials allow you to access our exclusive insightful intelligence and comprehensive analytical reports for one or multiple years